Adding Nalbuphine for Control of Intrathecal Morphine Pruritus
Status:
Recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
Intrathecal morphine causes intense itching which is very bothersome. Nalbuphine antagonizes
this effect when given intravenously. This trial is to find out if nalbuphine added to
intrathecal morphine has an effect on morphine related pruritus while still maintaining
adequate analgesia.